Tag:
Chroma Therapeutics
Latest Headlines
Latest Headlines
Battered Cell Therapeutics pays $5M to in-license AML drug
Bruised and battered by its setback on pixantrone, Cell Therapeutics ( $CTIC ) is adding a new drug to its pipeline, paying $5 million upfront to license the North, Central and South American rights to
Glaxo ropes in Chroma tech with $1B deal
GlaxoSmithKline has hammered out a new collaboration that will use technology from the UK's Chroma Therapeutics to identify four new drug programs for inflammatory disease. Glaxo is contributing to
